Duloxetine for the treatment of stress urinary incontinence in women: An integrated analysis of safety
- 1 March 2006
- journal article
- research article
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 125 (1), 120-128
- https://doi.org/10.1016/j.ejogrb.2005.08.006
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- VALIDATION OF A CLINICAL ALGORITHM TO DIAGNOSE STRESS URINARY INCONTINENCE FOR LARGE STUDIESJournal of Urology, 2004
- Synthesis and biological activity of some known and putative duloxetine metabolitesBioorganic & Medicinal Chemistry Letters, 2004
- Duloxetine vs placebo in the treatment of stress urinary incontinence: a four‐continent randomized clinical trialBJU International, 2004
- Duloxetine versus placebo in the treatment of European and Canadian women with stress urinary incontinenceBJOG: An International Journal of Obstetrics and Gynaecology, 2004
- Duloxetine Versus Placebo for the Treatment of North American Women With Stress Urinary IncontinenceJournal of Urology, 2003
- Pharmacological agents used for the treatment of stress urinary incontinence in womenCurrent Medical Research and Opinion, 2003
- Duloxetine versus placebo in the treatment of stress urinary incontinenceAmerican Journal of Obstetrics and Gynecology, 2002
- The standardisation of terminology of lower urinary tract function: Report from the standardisation sub‐committee of the International Continence SocietyNeurourology and Urodynamics, 2002
- Comparative Affinity of Duloxetine and Venlafaxine for Serotonin and Norepinephrine Transporters in vitro and in vivo, Human Serotonin Receptor Subtypes, and Other Neuronal ReceptorsNeuropsychopharmacology, 2001
- Adverse Reactions of Selective Serotonin Reuptake InhibitorsDrug Safety, 1999